藥物發現外包服務市場-按服務類型（化學、生物）、挖掘類型（小分子和大分子）、疾病模型（體外、細胞和動物模型）、治療領域（糖尿病、神經病學、腫瘤學）、全球預測(2023-2032)

由於基因療法和單株抗體等生物製劑的快速發展，藥物發現外包服務市場規模從 2023 年到 2032 年的年複合成長率預計將達到 8.2%。

為了滿足個別患者的需求，新型生物製劑和個人化醫療解決方案的蓬勃發展導致生物製藥研發活動對外包服務的需求更大。舉個例子，2021年1月，Charles River Laboratories International與生物製藥服務提供者JADE Biomedical合作，擴大其全球生物製劑測試能力，同時滿足生物製劑治療（主要是細胞和基因療法）的需求。外包提供者對服務的日益關注，例如現實世界的證據生成以及以患者為中心的試驗設計，以提高臨床研究的效率，也將有助於市場的成長。

藥物發現外包服務業根據服務類型、藥物類型、疾病模型、治療領域和區域進行細分。

從服務類型來看，2023-2032年化學服務領域的市場規模將錄得可觀的年複合成長率。藥物發現外包化學服務在製藥和生物技術行業簡化和加快藥物開發過程中發揮關鍵作用。外包計算化學服務以滿足虛擬篩選、分子建模和基於結構的藥物設計等用途的重要性日益凸顯，也將有助於該領域的成長。

以治療領域為基礎，神經病學領域的藥物發現外包服務產業價值預計將擴大到2032年。這一成長可歸因於阿茲海默症、帕金森氏症和多發性硬化症的更高負擔以及隨後的需求開發有效的治療方法。外包神經病學藥物發現服務的一些優點包括加速研發活動、降低成本以及更容易獲得專業知識。

從地區來看，由於存在龐大的人才庫、具有成本效益的勞動力和有利的監管環境，預計到 2032 年，亞太地區藥物發現外包服務市場規模將出現顯著的年複合成長率。對降低成本、獲取專業知識和加速藥物開發過程的日益成長的需求迫使許多製藥和生物技術公司轉向外包藥物發現服務。與智慧財產權、臨床試驗和資料安全相關的不斷變化的監管環境也將促進區域產業的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：藥物發現外包服務業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 全球慢性病盛行率不斷上升
    • 對外包新藥和療法的需求不斷增加
    • 製藥和生技公司增加研發支出
    • 藥物發現的技術不斷進步
  • 產業陷阱與挑戰
    • 智慧財產權問題
• 成長潛力分析
• COVID-19 影響分析
• 監管環境
  • 美國
  • 歐洲
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
  • Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
  • Laboratory Corporation of America Holdings (Covance Inc.)
  • IQVIA (Quintiles IMS Holdings, Inc.)
  • Eurofins Scientific
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：藥物發現外包服務市場：依服務類型，2018 - 2032

• 主要動向：依服務類型
• 化學服務
• 生物服務

第 6 章：藥物發現外包服務市場：依藥物類型，2018 - 2032

• 主要動向：依藥物類型
• 小分子藥物
• 大分子藥物

第 7 章：藥物發現外包服務市場：依疾病模型，2018 - 2032

• 主要動向：依疾病模型
• 體外模型
• 動物模型
• 蜂窩模型
• 其他疾病模型

第 8 章：藥物發現外包服務市場：依治療領域，2018 - 2032

• 主要動向：依治療領域
• 糖尿病
• 神經病學
• 腫瘤學
• 傳染性疾病
• 其他治療領域

第 9 章：藥物發現外包服務市場：按地區分類，2018 - 2032

• 主要動向：按地區
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 中東和非洲其他地區

第 10 章：公司簡介

• Charles River Laboratories International, Inc.
• IQVIA (Quintiles IMS Holdings, Inc.)
• Laboratory Corporation of America Holdings (Covance Inc.)
• Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
• WuXi AppTec
• Eurofins Scientific
• GenScript ProBio (Genscript Biotech Corporation)
• Aragen Life Sciences Ltd.
• Syngene International Limited
• Aurigene Pharmaceutical Services Ltd.
• Pharmaron
• Shanghai ChemPartner
• Jubilant Biosys Ltd (Jubilant Pharmova Limited)

Drug Discovery Outsourcing Services Market size is poised to record 8.2% CAGR from 2023-2032, on account of the rapid advances in biologics, including gene therapies and monoclonal antibodies.

The surging developments in novel biologics and personalized medicine solutions to cater to individual patients is leading to the greater demand for outsourcing services in biopharmaceutical R&D activities. To cite an instance, in January 2021, Charles River Laboratories International partnered with biopharma service provider JADE Biomedical to expand its global biologics testing capabilities while accommodating the demand for biologics therapeutics, mainly cell and gene therapies. The growing focus of outsourcing providers on services, such as real-world evidence generation as well as patient-centric trial designs for improved efficiency of clinical research will also contribute to the market growth.

The drug discovery outsourcing services industry is segmented based on service type, drug type, disease model, therapeutic area, and region.

In terms of service type, the market size from the chemistry services segment will record appreciable CAGR from 2023-2032. Drug discovery outsourcing chemistry services are playing pivotal role in the pharmaceutical and biotechnology industries in streamlining and expediting the drug development process. The surging importance of outsourcing computational chemistry services to cater to uses in virtual screening, molecular modeling, and structure-based drug design will also contribute to the segment growth.

On the basis of therapeutic area, the drug discovery outsourcing services industry value from the neurology segment is projected to expand up to 2032. The growth can be attributed to the higher burden of Alzheimer's disease, Parkinson's disease, and multiple sclerosis along with the subsequent need for the development of their effective treatments. Accelerated R&D activities, reduces costs, and the improved access to specialized expertise are some advantages of outsourcing neurology drug discovery services.

Regionally, the APAC drug discovery outsourcing services market size is projected to observe notable CAGR through 2032 due to the presence of large talent pools, cost-effective labor, and favorable regulatory environments. The surging need for reducing costs, accessing specialized expertise, and accelerating the drug development process has compelled numerous pharmaceutical and biotechnology companies to turn to outsourcing for drug discovery services. The evolving regulatory landscape related to intellectual property, clinical trials, and data security will also add to the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Drug discovery outsourcing services industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Service type trends
  • 2.1.4 Drug type trends
  • 2.1.5 Disease model trends
  • 2.1.6 Therapeutic area trends

Chapter 3 Drug Discovery Outsourcing Services Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic diseases globally
    • 3.2.1.2 Increasing demand for outsourcing novel drugs and therapeutics
    • 3.2.1.3 Increasing R&D expenditure by pharmaceutical and biotechnology companies
    • 3.2.1.4 Increasing technological advancements in drug discovery
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Intellectual property concerns
• 3.3 Growth potential analysis
  • 3.3.1 By service type
  • 3.3.2 By drug type
  • 3.3.3 By disease model
  • 3.3.4 By therapeutic area
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
  • 4.1.2 Laboratory Corporation of America Holdings (Covance Inc.)
  • 4.1.3 IQVIA (Quintiles IMS Holdings, Inc.)
  • 4.1.4 Eurofins Scientific
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategy dashboard, 2022

Chapter 5 Drug Discovery Outsourcing Services Market, By Service Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by service type
• 5.2 Chemistry services
• 5.3 Biological services

Chapter 6 Drug Discovery Outsourcing Services Market, By Drug Type, 2018 - 2032 (USD Million)

• 6.1 Key trends, by drug type
• 6.2 Small-molecule drugs
• 6.3 Large-molecule drugs

Chapter 7 Drug Discovery Outsourcing Services Market, By Disease Model, 2018 - 2032 (USD Million)

• 7.1 Key trends, by disease model
• 7.2 In vitro models
• 7.3 Animal models
• 7.4 Cellular models
• 7.5 Other disease models

Chapter 8 Drug Discovery Outsourcing Services Market, By Therapeutic Area, 2018 - 2032 (USD Million)

• 8.1 Key trends, by therapeutic area
• 8.2 Diabetes
• 8.3 Neurology
• 8.4 Oncology
• 8.5 Infectious diseases
• 8.6 Other therapeutic areas

Chapter 9 Drug Discovery Outsourcing Services Market, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Charles River Laboratories International, Inc.
• 10.2 IQVIA (Quintiles IMS Holdings, Inc.)
• 10.3 Laboratory Corporation of America Holdings (Covance Inc.)
• 10.4 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
• 10.5 WuXi AppTec
• 10.6 Eurofins Scientific
• 10.7 GenScript ProBio (Genscript Biotech Corporation)
• 10.8 Aragen Life Sciences Ltd.
• 10.9 Syngene International Limited
• 10.10 Aurigene Pharmaceutical Services Ltd.
• 10.11 Pharmaron
• 10.12 Shanghai ChemPartner
• 10.13 Jubilant Biosys Ltd (Jubilant Pharmova Limited)

Data Tables

• TABLE 1 Market revenue, by service type (2022)
• TABLE 2 Market revenue, by drug type (2022)
• TABLE 3 Market revenue, by disease model (2022)
• TABLE 4 Market revenue, by therapeutic area (2022)
• TABLE 5 Global drug discovery outsourcing services market size, by region, 2018 - 2024 (USD Million)
• TABLE 6 Global drug discovery outsourcing services market size, by region, 2025 - 2032 (USD Million)
• TABLE 7 Global drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 8 Global drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 9 Global drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 10 Global drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 11 Global drug discovery outsourcing services market size, by disease model, 2018 - 2024 (USD Million)
• TABLE 12 Global drug discovery outsourcing services market size, by disease model, 2025 - 2032 (USD Million)
• TABLE 13 Global drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 14 Global drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 15 Industry impact forces
• TABLE 16 Competitive benchmarking of major market players
• TABLE 17 Competitive positioning matrix: Classification criteria
• TABLE 18 Chemistry services market size, 2018 - 2024 (USD Million)
• TABLE 19 Chemistry services market size, 2025 - 2032 (USD Million)
• TABLE 20 Biological services market size, 2018 - 2024 (USD Million)
• TABLE 21 Biological services market size, 2025 - 2032 (USD Million)
• TABLE 22 Small-molecule drugs market size, 2018 - 2024 (USD Million)
• TABLE 23 Small-molecule drugs market size, 2025 - 2032 (USD Million)
• TABLE 24 Large-molecule drugs market size, 2018 - 2024 (USD Million)
• TABLE 25 Large-molecule drugs market size, 2025 - 2032 (USD Million)
• TABLE 26 In vitro models market size, 2018 - 2024 (USD Million)
• TABLE 27 In vitro models market size, 2025 - 2032 (USD Million)
• TABLE 28 Animal models market size, 2018 - 2024 (USD Million)
• TABLE 29 Animal models market size, 2025 - 2032 (USD Million)
• TABLE 30 Cellular models market size, 2018 - 2024 (USD Million)
• TABLE 31 Cellular models market size, 2025 - 2032 (USD Million)
• TABLE 32 Other disease models market size, 2018 - 2024 (USD Million)
• TABLE 33 Other disease models market size, 2025 - 2032 (USD Million)
• TABLE 34 Diabetes market size, 2018 - 2024 (USD Million)
• TABLE 35 Diabetes market size, 2025 - 2032 (USD Million)
• TABLE 36 Neurology market size, 2018 - 2024 (USD Million)
• TABLE 37 Neurology market size, 2025 - 2032 (USD Million)
• TABLE 38 Oncology market size, 2018 - 2024 (USD Million)
• TABLE 39 Oncology market size, 2025 - 2032 (USD Million)
• TABLE 40 Infectious diseases market size, 2018 - 2024 (USD Million)
• TABLE 41 Infectious diseases market size, 2025 - 2032 (USD Million)
• TABLE 42 Other therapeutic areas market size, 2018 - 2024 (USD Million)
• TABLE 43 Other therapeutic areas market size, 2025 - 2032 (USD Million)
• TABLE 44 North America drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 45 North America drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 46 North America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 47 North America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 48 North America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 49 North America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 50 North America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 51 North America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 52 North America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 53 North America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 54 U.S. drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 55 U.S. drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 56 U.S. drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 57 U.S. drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 58 U.S. drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 59 U.S. drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 60 U.S. drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 61 U.S. drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 62 Canada drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 63 Canada drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 64 Canada drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 65 Canada drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 66 Canada drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 67 Canada drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 68 Canada drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 69 Canada drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 70 Europe drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 71 Europe drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 72 Europe drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 73 Europe drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 74 Europe drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 75 Europe drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 76 Europe drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 77 Europe drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 78 Europe drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 79 Europe drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 80 Germany drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 81 Germany drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 82 Germany drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 83 Germany drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 84 Germany drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 85 Germany drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 86 Germany drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 87 Germany drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 88 UK drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 89 UK drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 90 UK drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 91 UK drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 92 UK drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 93 UK drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 94 UK drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 95 UK drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 96 France drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 97 France drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 98 France drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 99 France drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 100 France drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 101 France drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 102 France drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 103 France drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 104 Italy drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 105 Italy drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 106 Italy drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 107 Italy drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 108 Italy drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 109 Italy drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 110 Italy drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 111 Italy drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 112 Spain drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 113 Spain drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 114 Spain drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 115 Spain drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 116 Spain drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 117 Spain drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 118 Spain drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 119 Spain drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 120 Rest of Europe drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 121 Rest of Europe drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 122 Rest of Europe drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 123 Rest of Europe drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 124 Rest of Europe drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 125 Rest of Europe drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 126 Rest of Europe drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 127 Rest of Europe drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 128 Asia Pacific drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 129 Asia Pacific drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 130 Asia Pacific drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 131 Asia Pacific drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 132 Asia Pacific drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 133 Asia Pacific drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 134 Asia Pacific drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 135 Asia Pacific drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 136 Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 137 Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 138 China drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 139 China drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 140 China drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 141 China drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 142 China drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 143 China drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 144 China drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 145 China drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 146 Japan discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 147 Japan discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 148 Japan discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 149 Japan discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 150 Japan discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 151 Japan discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 152 Japan discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 153 Japan discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 154 India drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 155 India drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 156 India drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 157 India drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 158 India drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 159 India drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 160 India drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 161 India drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 162 Australia drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 163 Australia drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 164 Australia drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 165 Australia drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 166 Australia drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 167 Australia drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 168 Australia drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 169 Australia drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 170 Rest of Asia Pacific drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 171 Rest of Asia Pacific drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 172 Rest of Asia Pacific drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 173 Rest of Asia Pacific drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 174 Rest of Asia Pacific drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 175 Rest of Asia Pacific drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 176 Rest of Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 177 Rest of Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 178 Latin America drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 179 Latin America drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 180 Latin America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 181 Latin America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 182 Latin America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 183 Latin America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 184 Latin America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 185 Latin America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 186 Latin America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 187 Latin America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 188 Brazil drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 189 Brazil drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 190 Brazil drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 191 Brazil drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 192 Brazil drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 193 Brazil drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 194 Brazil drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 195 Brazil drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 196 Mexico discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 197 Mexico discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 198 Mexico discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 199 Mexico discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 200 Mexico discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 201 Mexico discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 202 Mexico discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 203 Mexico discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 204 Rest of Latin America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 205 Rest of Latin America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 206 Rest of Latin America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 207 Rest of Latin America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 208 Rest of Latin America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 209 Rest of Latin America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 210 Rest of Latin America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 211 Rest of Latin America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 212 Middle East & Africa drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 213 Middle East & Africa drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 214 Middle East & Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 215 Middle East & Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 216 Middle East & Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 217 Middle East & Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 218 Middle East & Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 219 Middle East & Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 220 Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 221 Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 222 South Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 223 South Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 224 South Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 225 South Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 226 South Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 227 South Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 228 South Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 229 South Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 230 Saudi Arabia discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 231 Saudi Arabia discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 232 Saudi Arabia discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 233 Saudi Arabia discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 234 Saudi Arabia discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 235 Saudi Arabia discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 236 Saudi Arabia discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 237 Saudi Arabia discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 238 Rest of Middle East & Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 239 Rest of Middle East & Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 240 Rest of Middle East & Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 241 Rest of Middle East & Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 242 Rest of Middle East & Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 243 Rest of Middle East & Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 244 Rest of Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 245 Rest of Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Profile break-up of primary respondents
• FIG 6 Drug discovery outsourcing services 360 degree synopsis, 2018 - 2032
• FIG 7 Industry ecosystem analysis
• FIG 8 Growth potential analysis, by service type
• FIG 9 Growth potential analysis, by drug type
• FIG 10 Growth potential analysis, by disease model
• FIG 11 Growth potential analysis, by therapeutic area
• FIG 12 Porter's analysis
• FIG 13 PESTEL analysis
• FIG 14 Company matrix analysis, 2022
• FIG 15 Competitive analysis of major market players
• FIG 16 Competitive positioning matrix, 2022
• FIG 17 Strategy dashboard, 2022